Suzon, Bienvenida Q.
HRN: 19-81-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/14/2022
06/20/2022
IV
1.5
Q6
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes